Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

L. Kappos, R. Gold, D. H. Miller, D.G. MacManus, E. Havrdova, V. Limmroth, C.H. Polman, K. Schmierer, T.A. Yousry, M.H. Yang, M. Eraksoy, E. Meluzinova, I. Rektor, K.T. Dawson, A.W. Sandrock, G.N. O'Neill

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1463-1472
Issue number9648
Publication statusPublished - 2008

Cite this